StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 15/304% below fair value
$14.72−0.07 (-0.47%)

Close on Nov 13, 2026Market cap $293.18MP/E 32.7Yield –

InfuSystem gross margin

Gross margin is gross profit as a percentage of revenue.

InfuSystem's gross margin for the twelve months ending Sep 30, 2026 was 57.6%. For fiscal 2025 it was 56.0%, against 52.2% the year before. The highest annual figure on record is 73.5% in fiscal 2009.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202556.0%+3.8
FY2024Dec 31, 202452.2%+2.0
FY2023Dec 31, 202350.2%−4.9
FY2022Dec 31, 202255.1%−2.1
FY2021Dec 31, 202157.2%−3.2
FY2020Dec 31, 202060.3%+2.5
FY2019Dec 31, 201957.8%−1.1
FY2018Dec 31, 201858.9%−2.1
FY2017Dec 31, 201761.0%−2.5
FY2016Dec 31, 201663.5%−6.9
FY2015Dec 31, 201570.3%−0.9
FY2014Dec 31, 201471.2%+1.1
FY2013Dec 31, 201370.1%−2.8
FY2012Dec 31, 201272.9%+8.2
FY2011Dec 31, 201164.7%−6.3
FY2010Dec 31, 201071.0%−2.5
FY2009Dec 31, 200973.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202657.8%+0.7
Q2 FY2026Jun 30, 202658.0%+2.8
Q1 FY2026Mar 31, 202658.4%+3.2
Q4 FY2025Dec 31, 202556.4%+2.6
Q3 FY2025Sep 30, 202557.1%+3.1
Q2 FY2025Jun 30, 202555.2%+5.7
Q1 FY2025Mar 31, 202555.2%+3.7
Q4 FY2024Dec 31, 202453.8%+1.2
Q3 FY2024Sep 30, 202453.9%+5.0
Q2 FY2024Jun 30, 202449.5%−0.4
Q1 FY2024Mar 31, 202451.5%+2.3
Q4 FY2023Dec 31, 202352.6%+3.8
Q3 FY2023Sep 30, 202348.9%−10.5
Q2 FY2023Jun 30, 202349.9%−5.2
Q1 FY2023Mar 31, 202349.2%−8.2
Q4 FY2022Dec 31, 202248.8%−2.7
Q3 FY2022Sep 30, 202259.5%+2.0
Q2 FY2022Jun 30, 202255.1%−5.5
Q1 FY2022Mar 31, 202257.4%−2.2
Q4 FY2021Dec 31, 202151.5%−9.2
Q3 FY2021Sep 30, 202157.4%−2.8
Q2 FY2021Jun 30, 202160.6%−0.9
Q1 FY2021Mar 31, 202159.6%+0.8
Q4 FY2020Dec 31, 202060.7%+1.0
Q3 FY2020Sep 30, 202060.2%+3.2
Q2 FY2020Jun 30, 202061.5%+3.9
Q1 FY2020Mar 31, 202058.8%+1.9
Q4 FY2019Dec 31, 201959.6%+2.9
Q3 FY2019Sep 30, 201957.0%−1.1
Q2 FY2019Jun 30, 201957.6%−1.4
Q1 FY2019Mar 31, 201956.8%−5.3
Q4 FY2018Dec 31, 201856.8%−3.2
Q3 FY2018Sep 30, 201858.0%−4.8
Q2 FY2018Jun 30, 201859.0%−2.0
Q1 FY2018Mar 31, 201862.1%+1.8
Q4 FY2017Dec 31, 201760.0%−3.2
Q3 FY2017Sep 30, 201762.8%–
Q2 FY2017Jun 30, 201761.0%–
Q1 FY2017Mar 31, 201760.3%–
Q4 FY2016Dec 31, 201663.2%–

More InfuSystem figures

See a number that looks wrong?